The Discounted Cash Flow (DCF) valuation of Bal Pharma Ltd (BALPHARMA.NS) is 54.70 INR. With the latest stock price at 100.09 INR, the upside of Bal Pharma Ltd based on DCF is -45.4%.
Based on the latest price of 100.09 INR and our DCF valuation, Bal Pharma Ltd (BALPHARMA.NS) is a sell. selling BALPHARMA.NS stocks now will result in a potential gain of 45.4%.
| Range | Selected | |
| WACC / Discount Rate | 13.2% - 15.9% | 14.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 38.66 - 77.97 | 54.70 |
| Upside | -61.4% - -22.1% | -45.4% |